Proof of Usefulness Report

Genexgen

Analysis completed on 3/20/2026

+31

Proof of Usefulness Score

You're In Business

The submission contains highly exaggerated and unverifiable claims ('most people have used my product', 'everyone' for audience reach). While the market timing for health span technology is relevant, the lack of verifiable metrics, technical details, and nonsensical financial figures ('all time marketcap: 2500000') result in a very low score, indicative of minimal to no credible traction.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+18.75

Audience Reach Impact+1.0

Technical Innovation+3.75

Evidence Of Traction+1.25

Market Timing Relevance+10.0

Functional Completeness+0.25

Subtotal+35

Usefulness Multiplierx0.88

Final Score+31

Project Details

Project URL

genexgen.com

Description

We leverage next-gen epigenetic editing and machine learning to create precision therapeutics that reset dysfunctional immune pathways to extend human health span

Algorithm Insights

Market Position

Growing utility with room for optimization

User Engagement

Documented reach suggests active user community

Technical Stack

Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline